127 related articles for article (PubMed ID: 37058951)
1. Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.
Murphy JD; Axiak-Bechtel S; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Shiomitsu K
Vet Immunol Immunopathol; 2023 May; 259():110594. PubMed ID: 37058951
[TBL] [Abstract][Full Text] [Related]
2. Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma.
Murphy JD; Shiomitsu K; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Axiak-Bechtel S
Vet Immunol Immunopathol; 2023 Mar; 257():110560. PubMed ID: 36804838
[TBL] [Abstract][Full Text] [Related]
3. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
4. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
[TBL] [Abstract][Full Text] [Related]
6. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
[TBL] [Abstract][Full Text] [Related]
7. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
[TBL] [Abstract][Full Text] [Related]
8. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas.
Mansoori M; Mirzaei A; Abdi Rad I; Mahmodlou R; Mansouri F; Saeednejad Zanjani L; Asadi-Lari Z; Madjd Z
Med J Islam Repub Iran; 2021; 35():148. PubMed ID: 35321364
[No Abstract] [Full Text] [Related]
10. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
[TBL] [Abstract][Full Text] [Related]
11. Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.
Ohkawa Y; Zhang P; Momota H; Kato A; Hashimoto N; Ohmi Y; Bhuiyan RH; Farhana Y; Natsume A; Wakabayashi T; Furukawa K; Furukawa K
Cancer Sci; 2021 Sep; 112(9):3756-3768. PubMed ID: 34145699
[TBL] [Abstract][Full Text] [Related]
12. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Storck MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley MJ; Natarajan A; Datta K; Band V; Band H
Sci Rep; 2024 Jun; 14(1):13523. PubMed ID: 38866755
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuronal migration by JONES antibody is independent of 9-O-acetyl GD3 in GD3-synthase knockout mice.
Yang CR; Liour SS; Dasgupta S; Yu RK
J Neurosci Res; 2007 May; 85(7):1381-90. PubMed ID: 17385751
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
16. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
[TBL] [Abstract][Full Text] [Related]
17. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
Ruan S; Raj BK; Lloyd KO
J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
[TBL] [Abstract][Full Text] [Related]
18. St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity.
Zhang P; Ohkawa Y; Yamamoto S; Momota H; Kato A; Kaneko K; Natsume A; Farhana Y; Ohmi Y; Okajima T; Bhuiyan RH; Wakabayashi T; Furukawa K; Furukawa K
Nagoya J Med Sci; 2021 Aug; 83(3):535-549. PubMed ID: 34552288
[TBL] [Abstract][Full Text] [Related]
19. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
[TBL] [Abstract][Full Text] [Related]
20. Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas?
Mansoori M; Abdi Rad I; Mirzaei A; Tam KJ; Mohsen Hosseini S; Mahmodlu R; Mansouri F; Saeednejad Zanjani L; Madjd Z
J Appl Biomed; 2021 Dec; 19(4):181-189. PubMed ID: 34907737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
